Evidence map›Paper›PMID 36128871›Full record

ArticleAnnals of neurology2023

Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.

Kengo Miyamoto, Shinji Saiki, Hirotaka Matsumoto, Ayami Suzuki, Yuri Yamashita, Tatou Iseki, Shin-Ichi Ueno, Kenta Shiina, Tetsushi Kataura, Koji Kamagata and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Value of multi-parameterEJNMMI research · 2025
    Article
  9. Article
  10. Review
  11. Thyroid [IBRO neuroscience reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Kengo MiyamotoDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shinji SaikiDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-9732-8488
Hirotaka MatsumotoSchool of Information and Data Sciences, Nagasaki University, Nagasaki, Japan.
Ayami SuzukiDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yuri YamashitaDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tatou IsekiDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shin-Ichi UenoDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kenta ShiinaDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tetsushi KatauraDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Koji KamagataDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoko ImamichiDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yukiko SasazawaResearch Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Motoki FujimakiDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Wado AkamatsuCenter for Genomic and Regenerative Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nobutaka HattoriDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Juntendo University · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveParkinson's disease (PD) is a common neurodegenerative disease characterized by initial involvement of the olfactory bulb/amygdala or autonomic nerves followed by nigral degeneration. Although autonomic innervation strictly regulates multiorgan systems, including endocrine functions, circulation, and digestion, how dysautonomia in PD affects systemic metabolism has not been identified. In this study, we tried to estimate the pathogenic linkage of PD by nuclear medicine techniques, trans-omic analysis of blood samples, and cultured cell experiments.

methodsThyroid mediastinum ratio of

resultsSympathetic denervation of thyroid correlating with its cardiac denervation was confirmed in 1,158 patients with PD by MIBG scintigraphy. Among patients with drug-naïve PD, comprehensive metabolome analysis revealed decreased levels of thyroxine and insufficient fatty acid β-oxidation, which positively correlate with one another. Likewise, both plasma metabolome data and transcriptome data of circulating exosomal miRNAs, revealed specific enrichment of the peroxisome proliferator-activated receptor (PPARα) axis. Finally, association of thyroid hormone with PPARα-dependent β-oxidation regulation was confirmed by in vitro experiments.

interpretationOur findings suggest that interorgan communications between the thyroid and liver are disorganized in the early stage of PD, which would be a sensitive diagnostic biomarker for PD. ANN NEUROL 2023;93:303-316.

Indexed as

Neurodegenerative DiseasesParkinson Disease3-IodobenzylguanidineHeartHumansLiverPPAR alphaRadiopharmaceuticals3-IodobenzylguanidinePPAR alphaRadiopharmaceuticals

Identifiers

PMID36128871
PMCPMC10092289
OpenAlexW4296959111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.